Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNew revision number v3.6.3 is now shown, replacing the previous v3.6.2. This indicates the study record has been updated to a newer version, reflecting changes since the prior revision.SummaryDifference0.1%

- Check27 days agoChange DetectedThe revision history now shows a new revision entry (v3.6.2). This update reflects an update to the page's versioning record rather than substantive content changes.SummaryDifference0.1%

- Check34 days agoChange DetectedA new References section has been added to the study record page, listing sources cited in the record to support the information presented.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision v3.6.0 was added and the study now shows no longer looking for participants, replacing the previous revision v3.5.5.SummaryDifference0.3%

- Check48 days agoChange DetectedThe history now shows a new revision label, v3.5.5, replacing the previous v3.5.4, indicating an update to the study record.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry 'Revision: v3.5.4' has been added to the history, replacing the previous revision tag. This documents the latest update to the study record's revision metadata.SummaryDifference0.1%

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.